Teva Pharmaceutical Industries Ltd (TEVJF) Payables (2009 - 2026)
Teva Pharmaceutical Industries' (TEVJF) quarterly Payables came in at $2.7 billion in Q2 2026, up 8.93% YoY from $2.5 billion in Q2 2025, and up 4.82% on a QoQ basis from $2.6 billion in Q1 2026.
Teva Pharmaceutical Industries Ltd (TEVJF) Payables (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 18 years of Payables data on file, last reported at $2.7 billion in Q2 2026.
- Quarterly Payables rose 8.93% year-over-year to $2.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.7 billion (up 8.93% YoY) and the FY2025 annual result came in at $2.5 billion, up 14.89% from the prior year.
- Payables grew to $2.7 billion in Q2 2026, from $2.6 billion in the prior quarter.
- In the past five years, Payables ranged from a high of $2.7 billion in Q2 2026 to a low of $1.6 billion in Q3 2022.
- A 5-year average of $2.3 billion and a median of $2.4 billion in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables soared 39.45% — and 2024, when it decreased 15.33%.
- Tracing TEVJF's Payables over 5 years: stood at $1.9 billion in 2022, then surged by 37.89% to $2.6 billion in 2023, then declined by 15.33% to $2.2 billion in 2024, then climbed by 14.89% to $2.5 billion in 2025, then increased by 7.51% to $2.7 billion in 2026.
- The last three Payables figures came in at $2.7 billion (Q2 2026), $2.6 billion (Q1 2026), and $2.5 billion (Q4 2025), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.72 Bn |
| Mar 31, 2026 | 2.60 Bn |
| Dec 31, 2025 | 2.53 Bn |
| Sep 30, 2025 | 2.36 Bn |
| Jun 30, 2025 | 2.50 Bn |
| Mar 31, 2025 | 2.29 Bn |
| Dec 31, 2024 | 2.20 Bn |
| Sep 30, 2024 | 2.37 Bn |
| Jun 30, 2024 | 2.37 Bn |
| Mar 31, 2024 | 2.44 Bn |
| Dec 31, 2023 | 2.60 Bn |
| Sep 30, 2023 | 2.28 Bn |
| Jun 30, 2023 | 2.51 Bn |
| Mar 31, 2023 | 2.38 Bn |
| Dec 31, 2022 | 1.89 Bn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 1.90 Bn |
| Mar 31, 2022 | 1.75 Bn |
| Dec 31, 2021 | 1.69 Bn |
| Sep 30, 2021 | 1.51 Bn |